The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs

Author： Taylor Holly A.   Kuwana Ellen   Wilfond Benjamin S.  

Publisher： Routledge Ltd

ISSN： 1536-0075

Source： American Journal of Bioethics, Vol.14, Iss.4, 2014-04, pp. : 51-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Researchers Have an Ethical Obligation to Disclose the Availability of Off-Label Marketed Drugs

By Silber Tomas J.  

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 52-52

Routledge Ltd

Access to resources Recommend Favorite

The Relevance of Research Study Phase to Disclosure of Off-Label Drug Availability

By Baskaran Amrutha   Sade Robert M.  

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 53-54

Routledge Ltd

Access to resources Recommend Favorite

Detainee Ethics: Terrorists as Research Subjects

By Moreno Jonathan D.  

American Journal of Bioethics, Vol. 3, Iss. 4, 2003-0 ,pp. : 32-33

Routledge Ltd

Access to resources Recommend Favorite

Marketing Off-Label Uses to Physicians: FDA's Draft (Mis)Guidance

By Gass Andy   Wilson Jennifer  

American Journal of Bioethics, Vol. 8, Iss. 3, 2008-03 ,pp. : 1-3

Routledge Ltd

Access to resources Recommend Favorite

Vulnerable Subjects and Civic Professionalism: Would Six-Sigma Research and Research Ethics Consultation Solve the Vulnerability Problem?

By Marshall Mary  

American Journal of Bioethics, Vol. 4, Iss. 3, 2004-0 ,pp. : 54-55

Routledge Ltd

Access to resources Recommend Favorite